<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>An <z:chebi fb="0" ids="50114">estrogen</z:chebi>-dependent genetic-male transsexual had an extensive anterior wall <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo>, despite insignificant <z:hpo ids='HP_0001677'>coronary artery disease</z:hpo>, a subsequent mural <z:mp ids='MP_0005048'>thrombosis</z:mp>, and resultant multiple cardioarterial <z:hpo ids='HP_0001907'>thromboembolic events</z:hpo>, despite <z:chebi fb="5" ids="28304">heparin</z:chebi> therapy </plain></SENT>
<SENT sid="1" pm="."><plain>With an otherwise lack of cardiac risk factors, the patient was demonstrated to have an <z:hpo ids='HP_0001976'>antithrombin III deficiency</z:hpo> that resolved when conjugated <z:chebi fb="0" ids="50114">estrogen</z:chebi> therapy was withdrawn </plain></SENT>
<SENT sid="2" pm="."><plain>Although congenital, plasminogen-activator dysfunction, or <z:chebi fb="5" ids="28304">heparin</z:chebi>-induced etiologies could not be ruled out, we believe this case demonstrated an <z:chebi fb="0" ids="50114">estrogen</z:chebi>-induced-<z:hpo ids='HP_0001976'>antithrombin III deficiency</z:hpo> culminating in thrombotic diathesis </plain></SENT>
<SENT sid="3" pm="."><plain>This identifies a previously unrecognized population at risk </plain></SENT>
<SENT sid="4" pm="."><plain>Prophylactic and therapeutic considerations are discussed </plain></SENT>
</text></document>